The primary purpose of the study is to assess how well amivantamab in combination with lazertinib or in combination with chemotherapy works (antitumor activity) in participants with epidermal growth factor receptor mutated (EGFRm) non-small cell…
- Investigator
- Aline Fares
- Status
- Accepting Candidates
- Ages
- 18 Years - N/A
- Sexes
- All